CLVS Clovis Oncology Inc

Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.

$5.65  +0.10 (1.80%)
As of 03/04/2021 15:59:56 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
11/16/2011
104,529,652
9,528,990
$580,139,569
0.00%
SEC Edgar Online
10-Q
10-K
189464100
US1894641000
B6RS2B3

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-1.57
-9.84
3.53
232.58%
-224.41%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy